Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly, food and drug administration
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets.
Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound
Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its weight-loss medicine Zepbound.
MangoRx hits back at Eli Lilly’s weight loss drug copycat claims
MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this week for selling products claiming to contain tirzepatide
Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs
Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit
Mangoceuticals (MGRX) said it strongly refutes claims made in a lawsuit filed by Eli Lilly (LLY) over a compounded version of Lilly’s weight-loss drug tirzepatide. Read more here.
1h
Eli Lilly & Co. stock underperforms Tuesday when compared to competitors despite daily gains
Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
1h
on MSN
UK's NHS to block Eli Lilly's Alzheimer's drug on Wednesday, Telegraph reports
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...
FiercePharma
3h
Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'
A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...
Medpage Today on MSN
8h
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suit
In Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
The News Leader (Staunton) on MSN
1h
Five Waynesboro residents ask judge to force Lilly and Mares to certify upcoming election
A counter lawsuit asking a judge to force two Waynesboro Board of Election members to certify the Nov. 5 election was filed ...
STAT
8h
Pharmalittle: We’re reading about a probe of Pfizer and Lilly telehealth, pharma exec donations, and more
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
6d
on MSN
Lilly Ledbetter’s Enduring Vision
Her willingness to challenge the status quo helped shape a new era in corporate responsibility, writes Marc Benioff.
Opinion
8h
Opinion
Lilly Ledbetter's fight for equal pay was for all women
Lilly Ledbetter may have lost in the court of law, but she won in the court of public opinion as she brought attention to the ...
STAT
13h
Senators demand answers on telehealth platforms from Pfizer and Eli Lilly
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
5h
Pfizer, Lilly pressed about telehealth prescriber relationships, STAT reports
A group of lawmakers led by Senator Dick Durbin are seeking answers from Pfizer (PFE) and Eli Lilly (LLY) about their relationships with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
United Kingdom
Pfizer
Food and Drug Administration
Johnson & Johnson
Feedback